Defining the needs for next generation assays for tuberculosis.

@article{Denkinger2015DefiningTN,
  title={Defining the needs for next generation assays for tuberculosis.},
  author={Claudia M Denkinger and Sandra V. Kik and Daniela Maria Cirillo and Martina Casenghi and Thomas M. Shinnick and Karin Weyer and Chris Gilpin and Catharina Boehme and Marco Schito and Michael E. Kimerling and Madhukar Pai},
  journal={The Journal of infectious diseases},
  year={2015},
  volume={211 Suppl 2},
  pages={
          S29-38
        }
}
To accelerate the fight against tuberculosis, major diagnostic challenges need to be addressed urgently. Post-2015 targets are unlikely to be met without the use of novel diagnostics that are more accurate and can be used closer to where patients first seek care in affordable diagnostic algorithms. This article describes the efforts by the stakeholder community that led to the identification of the high-priority diagnostic needs in tuberculosis. Subsequently target product profiles for the high… CONTINUE READING

Tables and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 44 CITATIONS

Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity

  • Science Translational Medicine
  • 2017
VIEW 4 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Four-gene Pan-African Blood Signature Predicts Progression to Tuberculosis.

  • American journal of respiratory and critical care medicine
  • 2018
VIEW 2 EXCERPTS
CITES METHODS & BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 39 REFERENCES

Cost-effectiveness of rapid susceptibility testing against second-line drugs for tuberculosis

DW Dowdy, AV Hoog, M Shah, F. Cobelens
  • Int J Tuberc Lung Dis
  • 2014
VIEW 1 EXCERPT

Diagnostic Technology and Market Landscape

UNITAID. Tuberculosis
  • Geneva: World Health Organization,
  • 2014
VIEW 1 EXCERPT

Similar Papers